BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18473789)

  • 1. Mortality and morbidity of HIV infected patients receiving HAART: a cohort study.
    Panos G; Samonis G; Alexiou VG; Kavarnou GA; Charatsis G; Falagas ME
    Curr HIV Res; 2008 May; 6(3):257-60. PubMed ID: 18473789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
    Palella FJ; Baker RK; Moorman AC; Chmiel JS; Wood KC; Brooks JT; Holmberg SD;
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):27-34. PubMed ID: 16878047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
    Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
    HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.
    Krentz HB; Kliewer G; Gill MJ
    HIV Med; 2005 Mar; 6(2):99-106. PubMed ID: 15807715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.
    Yang CH; Huang YF; Hsiao CF; Yeh YL; Liou HR; Hung CC; Yang SY
    HIV Med; 2008 Aug; 9(7):535-43. PubMed ID: 18554309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.
    Crum NF; Riffenburgh RH; Wegner S; Agan BK; Tasker SA; Spooner KM; Armstrong AW; Fraser S; Wallace MR;
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):194-200. PubMed ID: 16394852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
    Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
    Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.
    Croxford S; Kitching A; Desai S; Kall M; Edelstein M; Skingsley A; Burns F; Copas A; Brown AE; Sullivan AK; Delpech V
    Lancet Public Health; 2017 Jan; 2(1):e35-e46. PubMed ID: 29249478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality.
    Pinto AN; Grey P; Shaik A; Cooper DA; Kelleher AD; Petoumenos K
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):936-941. PubMed ID: 29901415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of mortality among HIV-infected children receiving highly active antiretroviral therapy.
    Njom Nlend AE; Loussikila AB
    Med Mal Infect; 2017 Feb; 47(1):32-37. PubMed ID: 27609595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-related mortality in Jamaican children.
    Evans-Gilbert T; Pierre RB; Steel-Duncan J; Palmer P; Figueroa JP; Christie CD
    West Indian Med J; 2008 Jun; 57(3):265-8. PubMed ID: 19583126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and progression to AIDS after starting highly active antiretroviral therapy.
    van Sighem AI; van de Wiel MA; Ghani AC; Jambroes M; Reiss P; Gyssens IC; Brinkman K; Lange JM; de Wolf F;
    AIDS; 2003 Oct; 17(15):2227-36. PubMed ID: 14523280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011.
    Lee SH; Kim KH; Lee SG; Chen DH; Jung DS; Moon CS; Park JY; Chung JS; Kwak IS; Cho GJ
    J Korean Med Sci; 2013 Jan; 28(1):67-73. PubMed ID: 23341714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
    Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
    Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of highly active anti-retroviral therapy on reducing HIV/AIDS related death in Hebei, 1989-2013].
    Chen S; Ma L; Lu X; Li Y; Wang W; Wang Y; Zhao C; Zhang Y; Zhao H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 May; 36(5):460-4. PubMed ID: 26080634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil.
    Pacheco AG; Tuboi SH; May SB; Moreira LF; Ramadas L; Nunes EP; Merçon M; Faulhaber JC; Harrison LH; Schechter M
    J Acquir Immune Defic Syndr; 2009 Aug; 51(5):624-30. PubMed ID: 19430304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
    Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
    AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Abrams EJ; Carter RJ; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Clin Infect Dis; 2011 Nov; 53(10):1024-34. PubMed ID: 22002982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.
    Hessol NA; Kalinowski A; Benning L; Mullen J; Young M; Palella F; Anastos K; Detels R; Cohen MH
    Clin Infect Dis; 2007 Jan; 44(2):287-94. PubMed ID: 17173233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.